Patent · US Expired

Synthetic peptide and its uses

US5932483A · kind A · utility

4Cited by
6References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 5, 1996
Grant dateAug 3, 1999
Priority date
Expiry dateApr 5, 2016

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K14/472
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides a fragment of C1q which is characterized in that a plurality of such fragments selectively binds immune complexes or aggregated immunoglobulins in the presence of monomeric immunoglobulin. The invention also provides a synthetic peptide comprising the sequence: Leu Glu Gln Gly Glu Asn Val Phe Leu Gln Ala Thr 1 5 10 SEQ ID NO 2! or variants thereof capable of binding immunoglobulin. Like the C1q fragment, a plurality of the peptides can selectively bind immune complexes or aggregated immunoglobulins in the presence of monomeric immunoglobulin. As a result of this property, the fragments and peptides are well-adapted for removing immune complexes and aggregated immunoglobulins from fluids containing monomeric immunoglobulin, and for detecting or quantitating immune complexes in such fluids. The invention also provides a binding material for removing immune complexes or aggregated immunoglobulins from a fluid. The binding material comprises plural binding peptides, the peptides being characterized in that a plurality of them selectively binds immune complexes and aggregated immunoglobulins in the presence of monomeric immunoglobulin. The invention also provides …

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.